Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jun Ma
Institution:
Pudong New Area People's Hospital
Observed institution:
Pudong New Area People's Hospital
ORCID:
0009-0008-6777-6811
Observed ORCID:
0009-0008-6777-6811
OpenAlex ID:
A5082197639
A Phase 1b Study to Evaluate Safety and Efficacy of IBI188 in Combination with Azacitidine (AZA) As a First-Line Treatment in Subjects with Newly Diagnosed Higher Risk Myelodysplastic Syndrome
2022
·
Miao Miao
, Depei WU
, et al.
·
Blood
·
7
Mitoxantrone Hydrochloride Liposome Combined with Cytarabine As Induction Therapy for Patients with Newly Diagnosed Secondary Acute Myeloid Leukemia
2024
·
Yun Wang
, Weida Wang
, et al.
·
Blood
·
2
Bioequivalence and Safety of Two Formulations of Tofacitinib Citrate Tablets in Healthy Chinese Volunteers under Fasting and Fed Conditions: Randomized, Open‐Label, 2‐Period, Single‐Dose, Crossover Trials
2024
·
Yanping Liu
, Yuping Ning
, et al.
·
Journal of Clinical Pharmacy and Therapeutics
·
1
PDF
Bioequivalence study of two formulations of afatinib dimaleate tablets in healthy subjects under fasting conditions: A randomized, open-label, single-dose, crossover trial
2024
·
Yanping Liu
, Lang Lü
, et al.
·
International Journal of Clinical Pharmacology and Therapeutics
Disease Characteristics and Treatment Outcomes with HLX01: A Real-World Study in Patients with B-Cell Non-Hodgkin Lymphoma in China
2022
·
Jun Ma
, Li Zhiming
, et al.
·
Blood
Show more works
View as search
Works count:
5
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type